Search results
What do we know about Kate's cancer treatment?
BBC via AOL· 4 days agoHow many people get cancer? In the UK, one in two people develop some kind of cancer during their lifetime. There are more than 200 different types of &...
Nicole Brown Simpson's tragic murder and O.J.'s infamous escape: 30 years later
FOX 10 Phoenix· 6 days agoFOX Sports' Chris Myers discusses how the 1995 O.J. Simpson trial impacted sports community. It's...
FDA Expands Repotrectinib Label
Medscape· 6 days agoThe new accelerated approval for the TKI was based on the overall response rate in 48 patients.
Newswise Expert | Shilpa Gupta, Case Western Reserve University
Newswise· 2 days agoDr. Gupt
Nicole Brown Simpson’s murder 30 years later: Where are OJ's children now?
Fox News· 7 days agoWhen Nicole Brown Simpson was murdered alongside her friend Ron Goldman on June 12, 1994, her two...
Knight Therapeutics Inc. (TSE:GUD) Senior Officer Amal Khouri Sells 20,000 Shares
ETF DAILY NEWS· 4 days agoKnight Therapeutics Inc. (TSE:GUD – Get Free Report) Senior Officer Amal Khouri sold 20,000 shares of the company’s stock in a transaction on Monday, June 10th. The shares were sold at an average ...
Xencor shares target cut by BMO on plamotamab rights By Investing.com
Investing.com· 4 days agoThe reacquisition of plamotamab rights by Xencor comes as the market has shown a growing...
Stifel Nicolaus Increases Merus (NASDAQ:MRUS) Price Target to $99.00
ETF DAILY NEWS· 2 days agoMerus (NASDAQ:MRUS – Get Free Report) had its price target hoisted by research analysts at Stifel Nicolaus from $90.00 to $99.00 in a research note issued on Monday, Benzinga reports. The brokerage ...
BeiGene, Ltd. (NASDAQ:BGNE) Short Interest Update
ETF DAILY NEWS· 2 days agoBeiGene, Ltd. (NASDAQ:BGNE – Get Free Report) saw a large drop in short interest during the month of May. As of May 31st, there was short interest totalling 1,560,000 shares, a drop of 6.6% ...
Merus (MRUS) – Research Analysts’ Weekly Ratings Changes
ETF DAILY NEWS· 1 day ago6/17/2024 – Merus had its price target raised by analysts at Stifel Nicolaus from $90.00 to $99.00. 6/5/2024 – Merus had its price target lowered by analysts at Bank of America Co. from $80.00 to $76.00.